| abstract |
The fused pyrimidines of formula (I) and their pharmaceutically acceptable salts have activity as inhibitors of PI3K and are diseases or disorders resulting from abnormal cell proliferation, function or behavior associated with PI3 kinase (eg, Cancer, immune disorders, cardiovascular diseases, viral infections, inflammation, metabolic / endocrine disorders and neurological disorders). Methods for synthesizing these compounds are also described. |